ANOVA PANCAN result package
Francesco Iorio, EMBL - European Bioinformatics Institute
result parsing started on 2016-03-31 19:01:09 iorio@ebi.ac.uk
Drug Domain: GDSC1000_paper_set, Analysis Domain: panCancer
Individual drug analysis: 291
Drug details and screening numbers
Drug Name: KIN001-266
Drug ID: 291
Synonyms:
Brand name:
Target: MAP3K8 (COT)
Number of cell lines screened: 922
Screening concentration range(s): 0.078125 to 20 uM
Statistically significant associations identified = 1
association id |
FEATURE |
Drug id |
Propr |
Public |
Drug Name |
Drug Target |
N FEATURE pos |
N FEATURE neg |
log max Conc tested |
FEATURE neg logIC50 MEAN |
FEATURE pos logIC50 MEAN |
FEATURE deltaMEAN IC50 |
FEATURE IC50 effectSize |
FEATURE neg Glass delta |
FEATURE pos Glass delta |
ANOVA FEATURE pval |
Tissue ANOVA pval |
MSI ANOVA pval |
ANOVA FEATURE FDR % |
a165 |
EWSR1-FLI1_mut |
291 |
1 |
1 |
KIN001-266 |
MAP3K8 (COT) |
17 |
902 |
3 |
3.43 |
2.41 |
-1.02 |
0.9 . |
0.89 . |
1.4 * |
5.26e-05 |
7.76e-18 |
4.85e-01 |
5.2 |
All-tests volcano plot